NASDAQ: CPRX
Catalyst Pharmaceuticals Inc Stock Ownership - Who owns Catalyst Pharmaceuticals?

Insider buying vs selling

Have Catalyst Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Brian ElsberndChief ComplianceLegal Officer2025-09-0830,000$20.30
$609.00kSell
Brian ElsberndChief ComplianceLegal Officer2025-09-08112,475$2.24
$251.94kBuy
Brian ElsberndChief ComplianceLegal Officer2025-09-0430,000$19.52
$585.60kSell
Brian ElsberndChief ComplianceLegal Officer2025-09-0430,000$2.24
$67.20kBuy
Brian ElsberndChief ComplianceLegal Officer2025-09-0320,000$2.24
$44.80kBuy
Brian ElsberndChief ComplianceLegal Officer2025-09-0320,000$20.08
$401.60kSell
David S. TierneyDirector2025-08-2750,000$2.24
$112.00kBuy
Steve MillerChief Op. Scientific Officer2025-08-27110,000$2.24
$246.40kBuy
David S. TierneyDirector2025-08-2726,000$20.20
$525.20kSell
Steve MillerChief Op. Scientific Officer2025-08-26115,000$2.24
$257.60kBuy

1 of 7

CPRX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CPRX insiders and whales buy or sell their stock.

CPRX Shareholders

What type of owners hold Catalyst Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc15.44%18,900,438$373.47MInstitution
Vanguard Group Inc7.16%8,765,835$173.21MInstitution
Biomarin Pharmaceutical Inc5.45%6,666,667$131.73MInsider
State Street Corp4.48%5,478,388$108.25MInstitution
Patrick J. McEnany3.86%4,719,467$93.26MInsider
Hubert E. Md Huckel3.10%3,793,238$74.95MInsider
Renaissance Technologies LLC2.66%3,251,516$64.25MInstitution
Morgan Stanley2.60%3,183,523$62.91MInstitution
Deerfield Management Company LP2.35%2,879,476$56.90MInstitution
Geode Capital Management LLC2.34%2,866,683$56.65MInstitution

1 of 3

CPRX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CPRX82.70%15.97%Net BuyingNet Buying
FOLD66.49%33.51%Net SellingNet Selling
MLYS62.74%37.26%Net BuyingNet Buying
VCYT66.68%33.32%Net SellingNet Selling
BEAM85.71%14.29%Net SellingNet Selling

Catalyst Pharmaceuticals Stock Ownership FAQ

Who owns Catalyst Pharmaceuticals?

Catalyst Pharmaceuticals (NASDAQ: CPRX) is owned by 82.70% institutional shareholders, 15.97% Catalyst Pharmaceuticals insiders, and 1.33% retail investors. Biomarin Pharmaceutical Inc is the largest individual Catalyst Pharmaceuticals shareholder, owning 6.67M shares representing 5.45% of the company. Biomarin Pharmaceutical Inc's Catalyst Pharmaceuticals shares are currently valued at $133.80M.

If you're new to stock investing, here's how to buy Catalyst Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.